75.75
0.38%
+0.29
Merit Medical Systems, Inc. stock is currently priced at $75.75, with a 24-hour trading volume of 313.87K.
It has seen a +0.38% increased in the last 24 hours and a -5.47% declined in the past month.
The chart indicates a potential bullish trend, as the stock is above the $74.85 pivot point. If it approaches the $76.13 resistance level, significant changes may occur.
Merit Medical Systems, Inc. Stock (MMSI) Financials Data
Merit Medical Systems, Inc. (MMSI) Revenue 2023
MMSI reported a revenue (TTM) of $1.26 billion for the quarter ending December 31, 2023, a +9.24% rise year-over-year.
Merit Medical Systems, Inc. (MMSI) Net Income 2023
MMSI net income (TTM) was $94.41 million for the quarter ending December 31, 2023, a +26.70% increase year-over-year.
Merit Medical Systems, Inc. (MMSI) Cash Flow 2023
MMSI recorded a free cash flow (TTM) of $108.45 million for the quarter ending December 31, 2023, a +64.10% increase year-over-year.
Merit Medical Systems, Inc. (MMSI) Earnings per Share 2023
MMSI earnings per share (TTM) was $1.63 for the quarter ending December 31, 2023, a +25.38% growth year-over-year.
Merit Medical Systems, Inc. Stock (MMSI) Insider Trading
Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
---|---|---|---|---|---|---|---|
Wright Joseph | CHIEF COMMERCIAL OFFICER |
Mar 07 '24 |
Option Exercise |
28.20 |
25,000 |
705,000 |
67,223 |
Wright Joseph | CHIEF COMMERCIAL OFFICER |
Mar 07 '24 |
Sale |
75.68 |
25,000 |
1,891,925 |
42,223 |
Peterson Neil | CHIEF OPERATING OFFICER |
Mar 06 '24 |
Option Exercise |
44.80 |
7,500 |
336,000 |
14,819 |
Gunderson Thomas James | Director |
Mar 04 '24 |
Option Exercise |
34.40 |
25,000 |
860,000 |
37,414 |
Gunderson Thomas James | Director |
Mar 04 '24 |
Sale |
76.03 |
18,157 |
1,380,513 |
19,257 |
Evans Stephen C. | Director |
Mar 04 '24 |
Sale |
76.35 |
1,000 |
76,348 |
7,226 |
Millner F. Ann | Director |
Jan 22 '24 |
Option Exercise |
34.40 |
20,000 |
688,000 |
49,960 |
Millner F. Ann | Director |
Jan 22 '24 |
Sale |
80.00 |
20,000 |
1,600,000 |
29,960 |
LAMPROPOULOS FRED P | PRESIDENT AND CEO |
Aug 25 '23 |
Option Exercise |
28.20 |
200,000 |
5,640,000 |
1,167,916 |
LAMPROPOULOS FRED P | PRESIDENT AND CEO |
Aug 25 '23 |
Option Exercise |
28.20 |
6,000 |
169,200 |
12,888 |
Merit Medical Systems, Inc. Stock (MMSI) Latest News
Here's Why Merit Medical (MMSI) is a Strong Value Stock
Zacks Investment Research
Should You Invest in the Invesco S&P SmallCap Health Care ETF (PSCH)?
Zacks Investment Research
Merit Medical (MMSI) Launches FDA-Cleared Micro-Access System
Zacks Investment Research
Merit Medical Launches the Micro ACE™ Advanced Micro-Access System
GlobeNewswire Inc.
Merit Medical Systems to Announce First Quarter 2024 Results on April 30, 2024
GlobeNewswire Inc.
Why Merit Medical (MMSI) is a Top Value Stock for the Long-Term
Zacks Investment Research
About Merit Medical Systems, Inc.
Merit Medical Systems, Inc. designs, develops, manufactures, and markets various disposable medical devices for interventional, diagnostic, and therapeutic procedures in cardiology, radiology, oncology, critical care, and endoscopy. The company operates through Cardiovascular and Endoscopy segments. It provides various peripheral intervention products, including access, angiography, intervention, and drainage and biopsy products to alleviate patients suffering from peripheral vascular and non-vascular diseases; and cardiac intervention products to aid in the treatment of various cardiac conditions specific to interventional cardiology and electrophysiology, including cardiac rhythm management and lead management. The company also offers cardiovascular and critical care products comprising infection prevention and safety, and fluid management and monitoring devices. In addition, it provides interventional oncology and spine products, such as vertebral compression fractures; tumor ablation systems; inflation syringes; microspheres for treating hypervascularized tumors and liver cancer; polyvinyl alcohol particles to treat hypervascularized tumors; and microcatheters for the controlled and selective infusion of diagnostic, embolic, or therapeutic agents into vessels. Further, the company offers endoscopy products, such as non-vascular stents, esophageal stents, biliary stent systems, esophageal balloon dilators, inflation devices, and guide wires; and kits and accessories for endoscopy and bronchoscopy procedures. Additionally, it provides coated tubes and wires; and microelectromechanical systems sensor components. The company sells its products to hospitals and clinic-based physicians, technicians, and nurses through its direct sales force, distributors, original equipment manufacturer partners, or custom procedure tray manufacturers in the United States and internationally. Merit Medical Systems, Inc. was founded in 1987 and is headquartered in South Jordan, Utah.
Cap:
|
Volume (24h):